The best indicator for Labcorp (LH)
We backtested 366 indicators across daily, weekly and hourly charts on real Labcorp (LH) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Ichimoku Cloud
On the weekly chart, this is the strongest risk-adjusted edge we found for Labcorp (LH) over ~36.3 years — beating buy-and-hold by 2.4% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Labcorp (LH) — trailing buy-and-hold by 1.4% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Ichimoku Cloud ✓ | Weekly | 9.1% | 0.52 | -36.9% | 41.7% | 36 | 2.4% |
| 2 | Stochastic RSI ✓ | Weekly | 8.5% | 0.52 | -40.7% | 78.3% | 60 | 1.8% |
| 3 | CCI (50) ✓ | Weekly | 8.6% | 0.49 | -55.9% | 39.1% | 46 | 1.9% |
| 4 | SMA 20/50 Cross ✓ | Weekly | 8.9% | 0.48 | -48.4% | 64.7% | 17 | 2.1% |
| 5 | WMA 20/80 Cross ✓ | Weekly | 8.3% | 0.47 | -47.4% | 60.0% | 15 | 1.5% |
| 6 | Williams %R (50) ✓ | Weekly | 8.1% | 0.46 | -64.8% | 35.6% | 45 | 1.3% |
| 7 | SMA 50/200 Cross ✓ | Daily | 8.4% | 0.45 | -65.6% | 58.3% | 24 | 1.3% |
| 8 | SMA 15/60 Cross ✓ | Weekly | 8.0% | 0.45 | -56.8% | 68.8% | 16 | 1.2% |
| 9 | TRIX (15) ✓ | Weekly | 8.0% | 0.45 | -56.7% | 55.6% | 18 | 1.2% |
| 10 | SMA 10/40 Cross ✓ | Weekly | 7.6% | 0.43 | -54.7% | 61.5% | 26 | 0.8% |
| 11 | WMA 15/60 Cross ✓ | Weekly | 7.5% | 0.43 | -50.1% | 55.0% | 20 | 0.7% |
| 12 | TRIX (21) ✓ | Weekly | 8.0% | 0.45 | -55.7% | 64.3% | 14 | 1.2% |
| 13 | EMA 20/50 Cross ✓ | Weekly | 7.2% | 0.42 | -61.5% | 53.3% | 15 | 0.4% |
| 14 | Relative Volatility Index ✓ | Weekly | 7.7% | 0.42 | -67.3% | 49.5% | 103 | 0.9% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Labcorp (LH), Ichimoku Cloud on the weekly timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.